Breast cancer trials enrolling now: Could your patient benefit?February 18, 2022Breast CancerOncology
Experimental breast cancer immunotherapy treatment passes important hurdle in pilot studyFebruary 17, 2022OncologyBreast Cancer
ACIP issues adult vaccination schedule 2022February 17, 2022Infectious DiseasesVaccinesCOVID-19 UpdatesMixed TopicsPreventive Care
High praise, condemnation for CMS Aduhelm coverage planFebruary 17, 2022Alzheimer's & CognitionBusiness of MedicineNeurology
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinomaFebruary 17, 2022Oncology
Patients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022COVID-19 UpdatesRheumatology
Diversity among oncologists has not kept pace with the U.S. populationFebruary 17, 2022Diversity in MedicineMixed TopicsOncology
Biden’s FDA chief nominee narrowly wins Senate confirmationFebruary 17, 2022Business of MedicineCardiologyMixed Topics
Thirty-seven percent of COVID-19 patients lose sense of taste, study saysFebruary 17, 2022COVID-19 Updates
